RESUMEN
Since the human gene code had been broken,the high through-out technologies based on genome-wide analysis have been well developed and extensively applied in cancers,which brought the innovation for the discovery of the pathogenesis and targeted drugs development of the cancer.After the successful application of these technologies in lymphomas,for example,gene expression profile in the diffuse large B cell lymphoma and next-generation sequencing technologies in hairy cell leukemia and Waldentr(o)m's macroglobulinemia,more and more researchers have tried to applied kinds of high through-out technologies in lymphomas,expecting to make improvements for the pathogenesis and prognosis of lymphomas.Many of the results had been reported in the 54th ASH annual meeting.